The Global Breast Implants Market, by implant type (silicone breast implants and saline breast implants), by shape (round and anatomical), by application (reconstructive surgery and cosmetic surgery), by end user (hospitals and cosmetic clinics), and by region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 1,121.3 million in 2016 and is projected to exhibit a CAGR of 5.1% over the forecast period (2017 – 2025).
The breast implants market is expected to gain significant traction with increasing incidence of breast cancer and rising adoption of cosmetic and aesthetic procedures worldwide. According to breastcancer.org 2018, approximately 1 in 8 women which accounts for up to 12.4% of total female population, develops invasive breast cancer over the course in her lifetime.
Initiatives for assurance of product safety as well as launch of new devices to drive the global breast implants market growth
Rapid product developments by manufacturers that are approved by the FDA are factors augmenting growth of the global breast implants market. For instance, in May 2016, Sientra, Inc. received an FDA approval for four new breast implants that have additional profiling and sizing options for nine existing implants. Furthermore, in October 2016, a Breast Implant Register was launched in Europe to keep a track of faulty implants as a result of Breast Implant Scandal in 2010. This register is expected to be helpful for consumers to ensure refunds and reimbursement in case, they receive faulty devices. Advancements in technology and improvements in designs, materials, construction, and fill volumes are expected to accelerate the market growth. For instance, in April 2017, Mentor Worldwide LLC received an FDA approval for MemoryGel XTRA silicone gel-filled breast implant that will act as a first tissue breast expander with Dynamic Control Technology to provide precise and controlled expansion. Also, in June 2017, G&G Biotechnology introduced innovative B-Lite lightweight breast implants. These implants are the first and only lightweight breast implants.
Browse 36 Market Data Tables and 35 Figures spread through 155 Pages and in-depth TOC on “Brest Implants Market”- Global Forecast to 2025 by implant type (silicone breast implants and saline breast implants), by shape (round and anatomical), by application (reconstructive surgery and cosmetic surgery), by end user (hospitals and cosmetic clinics), and by region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa).
To know the latest trends and insights prevalent in the breast implants market, click the link below:
Key players are adopting collaborations and acquisitions strategies for increasing their product portfolio. For instance, in June 2017, Allergen, Inc. acquired Keller Medical — a developer of Keller funnel that is used in breast augmentation and implantation. Keller Funnel is an innovative component in cosmetic breast implant procedures, as it reduced patient-surgeon contact during the surgery. Moreover, in August 2016, Sientra, Inc. collaborated with Vesta — a unit of U.S.-based Lubrizol Life Sciences, for manufacturing breast implants in optimum safe and sterile environment of the plant.
Key Takeaways of the Breast Implants Market:
Some of the major players operating in the global breast implants market are Allergen, Inc., Mentor Worldwide LLC, GC Aesthetics Plc, Sientra, Inc., POLYTECH Health and Aesthetics GmBH, Establishment Labs S.A., LABORATORIES ARION, HANSBIOMED Co. Ltd., Groupe Sebbin SAS, and GG Biotechnology Ltd.